期刊文献+

原发性肝癌伴癌综合征研究进展 被引量:5

原发性肝癌伴癌综合征研究进展
原文传递
导出
摘要 原发性肝癌伴癌综合征(paraneoplastic syndrome,PNS)系指原发性肝癌(primary hepatic carcinoma,PHC)病人由于癌肿本身代谢异常或癌肿产生的一些物质进入血流并作用于远处组织,对机体产生各种影响而引起的一组症候群。伴癌综合征有时可先于肝脏症状出现。
出处 《中国实用外科杂志》 CSCD 北大核心 2010年第4期321-322,326,共3页 Chinese Journal of Practical Surgery
关键词 原发性肝癌伴癌综合征 原发性肝癌 paraneoplastic syndrome primary hepatic carcinoma
  • 相关文献

参考文献10

  • 1杨秉辉,夏景林.原发性肝癌的临床诊断与分期标准[J].中华肝脏病杂志,2001,9(6):324-324. 被引量:1013
  • 2CHU CW, HWANG SJ. Manifestations of hypercholesterolemia, hypoglycemia, erythrocytosis and hypercalcaemia in patients with hepatocellnlar carcinoma: Report of two cases [J]. J Gastroe Hepato,1999,14(8): 807-810.
  • 3LUO JC, Hwang SJ, Wu JC. Paraneoplastic syndromes in patients with hepatocellular carcinoma in Taiwan[J]. Cancer 1999, 86(5):799-804.
  • 4Yen TC, Hwang SJ, Wang CC, et al. Hypercalcemia and parathyroid hormone-related protein in hepatocellular carcinoma [J]. Liver, 1993,13(6):311-315.
  • 5Ohigashi T, Yoshioka K. Autocrine regulation of erythropoietin gene expression in human hepatocellular carcinoma cells [J]. Life Sci, 1996,58(5):421-427.
  • 6Yoshioka K, Thompson J.Inducible nitric oxide synthase expression and erythropoietin production in human hepatocellular carcinoma cells [J]. Biochem Biophys Res Commun, 1997,232(2): 702-706.
  • 7Horinouchi A, Miyamoto S. Erythropoietin mRNA in hepatocellular carcinomas and kidney in male B6C3F1 mice with secondary polycythemia[J]. Toxicol Pathol 1998,26(5):682-686.
  • 8Luo JC, Hwang, Wu JC et al. Paraneoplastic syndromes in patients with hepatocellular carcinoma in Taiwan [J ] Cancer, 1999, 86(5): 799-804.
  • 9张文洁,杨冬华.肝癌伴癌综合征的临床特征[J].中华消化杂志,2004,24(11):651-654. 被引量:14
  • 10冯晓玲,王志凤.原发性肝癌伴癌综合征的研究进展[J].中国肿瘤,2005,14(12):799-801. 被引量:5

二级参考文献23

  • 1李建静,武天明,王兰香.持续低血糖昏迷1例[J].疑难病杂志,2004,3(5):303-303. 被引量:3
  • 2张文洁,杨冬华.肝癌伴癌综合征的临床特征[J].中华消化杂志,2004,24(11):651-654. 被引量:14
  • 3叶任高.内科学[M].北京:人民卫生出版社,2001.294-307.
  • 4Hwang SJ, Chen CY, Wu JC, et al. Clinical study of hypercalceamia in patients with hepatocellulau carcinoma. Chin J Gastroenterol, 1989, 6: 182-186.
  • 5Hwang SJ, Lee SD, Chang CF, et al. Hypercholesterolaemia in patients with hepatocellular carcinoma. J Gastroenterol Hepatol, 1992,7:491-496.
  • 6Luo JC, Hwang SJ, Wu JC, et al. Clinical characteristics and prognosis of hepatocellular carcinoma patients with paraneoplastic syndromes. Hepatogastroenterology, 2002,49:1315-1319.
  • 7Hwang SJ, Lee SD, Wu JC, et al. Clinical evaluation of erythrocytosis in patients with hepatocellular carcinoma. Zhonghua Yi Xue Za Zhi(Tai Pei), 1994,53:262-269.
  • 8Furusawa A, Unoura M, Notsumata K, et al. Clinicopathological study of juvenile hepatocellular carcinoma. Nippon Shokakibyo Gakkai Zasshi, 1989, 86:2765-2772.
  • 9Kato A, Bando E, Shinozaki S,et al. Severe hypoglycemia and hypokalemia in association with liver metastases of gastric cancer[J]. Intern Med,2004,43 (9):824-828.
  • 10朱雅琪 朱权 金振锋.消化内科主任医生400问[M].北京:中国协和医科大学出版社,2001.435-437.

共引文献1025

同被引文献23

引证文献5

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部